Skip to main content

Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables.

Bai Y, Tolles J, Cheng H, Siddiqui S, Gopinath A, Pectasides E, Camp RL, Rimm DL, Molinaro AM

Publication: Lab Invest (2011) • Vol 91 • Page 1253-61PMID: 21519325View on PubMed

Purpose

The purpose of this paper was to determine the effects of cold ischemia time, surgical procedure type, and the analysis of tissue microarrays versus whole tissue sections on quantitative immunofluorescence of proteins and phospho-proteins usingAutomated Quantitative Analysis (AQUA).

Conclusion

Statistically insignificant differences were seen between core needle biopsies (CNB) and surgical resections (SR) in the antigenicity of phosphorylated extracellular-signal-regulated kinase (pERK), phosphorylated serine/threonine protein kinase (pAKT), phosphorylated Tyrosine (pTyr), and Ki67 when AQUA scores were obtained from tissue microarrays, while no differences were seen for estrogen receptor (ER) or p53. Upon evaluation of whole tissue sections, immunofluorescence staining of pAKT, pERK, ER, cytokeratin, and phosphorylated ribosomal protein S6 kinase beta-1 (pS6K1) was significantly lower in SR compared to CNB (p<0.05). At the same time, total AKT, ERK, S6K1, Ki67, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were not affected by surgical procedure type, however the authors subsequently determined their sample size was not large enough to detect total protein differences for these epitopes.

Studies (1)

Purpose

The purpose of this study was to determine the effects of cold ischemia time, surgical procedure type, and the analysis of tissue microarrays versus whole tissue sections on quantitative immunofluorescence of proteins and phospho-proteins using AQUA. The median time between acquisition of core needle biopsy and surgical resection was 27.5 days.

Summary of Findings

When a cohort of 20 paired CNB and SR were examined in a tissue microarray format (AQUA scores from 2 spots for each type of specimen were averaged), no statistically significant differences were seen in the antigenicity of pERK, pAKT, pTyr, ER, p53, or Ki67. However, insignificant decreases in pERK, pAKT, pTyr, and Ki67 were seen for SR compared with CNB. When whole tissue sections were evaluated from a second cohort of 14 matched CNB and SR, pAKT, pERK, ER, cytokeratin, and pS6K1 immunofluorescence was significantly lower in SR (average of 19 20x fields of view) compared to CNB (average of 11 20x fields of view; p<0.05). For ER, the authors report that none of the cases would have changed from an ER-positive status in the CNB to an ER-negative status with the SR. At the same time, total AKT, ERK, S6K1, Ki67, and GAPDH were not affected by surgical procedure type, however the authors subsequently determined their sample size was not large enough to detect total protein epitope differences for AKT, ERK, S6K1, Ki67, and GAPDH.

  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    ProteinTissue microarray
    Small moleculeImmunohistochemistry
    MorphologyFluorescent microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionCold ischemia time
    0 min
    1-5 h
    Biospecimen AcquisitionMethod of tissue acquisition
    Core needle biopsy
    Surgical resection
    Biospecimen Aliquots and ComponentsAliquot size/volume
    An average of 11 20x fields of view
    An average of 19 20x fields of view
    Two 1.5 mM tissue microarray cores
    Biospecimen Aliquots and ComponentsType of slide
    Tissue microarray
    Whole tissue section
    Immunohistochemistry SpecificTargeted peptide/protein
    AKT
    Cytokeratin
    ER
    ERK
    GAPDH
    Ki67
    S6K1
    p53
    pAKT
    pERK
    pS6K1
    pTyr